Literature DB >> 19132807

An intervention to improve spontaneous adverse drug reaction reporting by hospital physicians: a time series analysis in Spain.

Consuelo Pedrós1, Antoni Vallano, Gloria Cereza, Gemma Mendoza-Aran, Antònia Agustí, Cristina Aguilera, Immaculada Danés, Xavier Vidal, Josep M Arnau.   

Abstract

BACKGROUND: Spontaneous reporting of adverse drug reactions (ADRs) in hospitals is scarce and several obstacles to such reporting have been identified previously.
OBJECTIVE: To assess the effectiveness of a multifaceted intervention based on healthcare management agreements for improving spontaneous reporting of ADRs by physicians in a hospital setting.
METHODS: In 2003, the spontaneous reporting of ADRs was included as one of the objectives of hospital physicians at the Vall d'Hebron Hospital, Barcelona, Spain, within the context of management agreements between clinical services and hospital managers. A continuous intervention related to these management agreements, including periodic educational meetings and economic incentives, was then initiated. We carried out an ecological time series analysis and assessed the change in the total number of spontaneous reports of ADRs, and the number of serious ADRs, unexpected ADRs, and ADRs associated with new drugs between a period previous to the intervention (from 1998 to 2002) and the period during the intervention (from 2003 to 2005). A time series analysis with ARIMA (Auto-Regressive Integrated Moving Average) models was performed.
RESULTS: The median number of reported ADRs per year increased from 40 (range 23-55) in the first period to 224 (range 98-248) in the second period. In the first period, the monthly number of reported ADRs was stable (3.47 per month; 95% CI 1.90, 5.03), but in the second period the number increased progressively (increase of 0.74 per month; 95% CI 0.62, 0.86). In the second period, the proportion of reported serious ADRs increased nearly 2-fold (63.1% vs 32.5% in the first period). The absolute number of previously unknown or poorly known ADRs increased 4-fold in the second period (54 vs 13 in the first period). There was also an increase in the absolute number of suspected pharmacological exposures to new drugs (97 vs 28) and in the number of different new drugs suspected of causing ADRs (50 vs 19).
CONCLUSION: A continuous intervention based on healthcare management agreements with economic incentives and educational activities is associated with a quantitative and qualitative improvement of spontaneous reporting of ADRs by hospital physicians.

Mesh:

Year:  2009        PMID: 19132807     DOI: 10.2165/00002018-200932010-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN: 0114-5916            Impact factor:   5.606


  23 in total

1.  Physicians' attitudes towards voluntary reporting of adverse drug events.

Authors:  A Figueiras; F Tato; J Fontaiñas; B Takkouche; J J Gestal-Otero
Journal:  J Eval Clin Pract       Date:  2001-11       Impact factor: 2.431

2.  Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital.

Authors:  A Vallano; G Cereza; C Pedròs; A Agustí; I Danés; C Aguilera; J M Arnau
Journal:  Br J Clin Pharmacol       Date:  2005-12       Impact factor: 4.335

3.  Physicians' attitudes and adverse drug reaction reporting : a case-control study in Portugal.

Authors:  Maria T Herdeiro; Adolfo Figueiras; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  A small economic inducement to stimulate increased reporting of adverse drug reactions--a way of dealing with an old problem?

Authors:  M Bäckström; T Mjörndal
Journal:  Eur J Clin Pharmacol       Date:  2006-03-30       Impact factor: 2.953

5.  An educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trial.

Authors:  Adolfo Figueiras; Maria T Herdeiro; Jorge Polónia; Juan Jesus Gestal-Otero
Journal:  JAMA       Date:  2006-09-06       Impact factor: 56.272

6.  Adverse drug reactions leading to hospital admission.

Authors:  L Ibáñez; J R Laporte; X Carné
Journal:  Drug Saf       Date:  1991 Nov-Dec       Impact factor: 5.606

7.  Adverse drug reactions: finding the needle in the haystack.

Authors:  I R Edwards
Journal:  BMJ       Date:  1997-08-30

8.  Reporting of adverse drug reactions by hospital doctors and the response to intervention.

Authors:  P McGettigan; J Golden; R M Conroy; N Arthur; J Feely
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

9.  Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project.

Authors:  H D Scott; A Thacher-Renshaw; S E Rosenbaum; W J Waters; M Green; L G Andrews; G A Faich
Journal:  JAMA       Date:  1990-04-04       Impact factor: 56.272

Review 10.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

View more
  25 in total

1.  Workshop- and telephone-based interventions to improve adverse drug reaction reporting: a cluster-randomized trial in Portugal.

Authors:  Maria Teresa Herdeiro; Inês Ribeiro-Vaz; Mónica Ferreira; Jorge Polónia; Amílcar Falcão; Adolfo Figueiras
Journal:  Drug Saf       Date:  2012-08-01       Impact factor: 5.606

2.  Effect of an educational intervention to improve adverse drug reaction reporting in physicians: a cluster randomized controlled trial.

Authors:  Elena Lopez-Gonzalez; Maria T Herdeiro; María Piñeiro-Lamas; Adolfo Figueiras
Journal:  Drug Saf       Date:  2015-02       Impact factor: 5.606

3.  Ongoing challenges in pharmacovigilance.

Authors:  Gerald J Dal Pan
Journal:  Drug Saf       Date:  2014-01       Impact factor: 5.606

4.  A global view of undergraduate education in pharmacovigilance.

Authors:  Jenny Hartman; Linda Härmark; Eugène van Puijenbroek
Journal:  Eur J Clin Pharmacol       Date:  2017-03-17       Impact factor: 2.953

5.  Effect of Educational Interventions on Adverse Drug Reaction Reporting in a Cancer Institute in Japan: A Questionnaire Study.

Authors:  Masami Tsuchiya; Akihisa Esashi; Taku Obara; Kyoko Inooka; Nariyasu Mano; Chizuko Takamura
Journal:  Hosp Pharm       Date:  2018-04-13

Review 6.  Strategies to improve adverse drug reaction reporting: a critical and systematic review.

Authors:  Cristian Gonzalez-Gonzalez; Elena Lopez-Gonzalez; Maria T Herdeiro; Adolfo Figueiras
Journal:  Drug Saf       Date:  2013-05       Impact factor: 5.606

7.  Improving adverse drug reaction reporting in hospitals: results of the French Pharmacovigilance in Midi-Pyrénées region (PharmacoMIP) network 2-year pilot study.

Authors:  Mireille Gony; Kattalin Badie; Agnès Sommet; Julien Jacquot; Dominique Baudrin; Pierre Gauthier; Jean Louis Montastruc; Haleh Bagheri
Journal:  Drug Saf       Date:  2010-05-01       Impact factor: 5.606

8.  Promoting spontaneous adverse drug reaction reporting in hospitals using a hyperlink to the online reporting form: an ecological study in Portugal.

Authors:  Inês Ribeiro-Vaz; Cristina Santos; Altamiro da Costa-Pereira; Ricardo Cruz-Correia
Journal:  Drug Saf       Date:  2012-05-01       Impact factor: 5.606

9.  Effect of an intervention on the features of adverse drug reactions spontaneously reported in a hospital.

Authors:  Gloria Cereza; Antonia Agustí; Consuelo Pedrós; Antonio Vallano; Cristina Aguilera; Immaculada Danés; Xavier Vidal; Josep Maria Arnau
Journal:  Eur J Clin Pharmacol       Date:  2010-06-16       Impact factor: 2.953

Review 10.  Systematic review: Effects, design choices, and context of pay-for-performance in health care.

Authors:  Pieter Van Herck; Delphine De Smedt; Lieven Annemans; Roy Remmen; Meredith B Rosenthal; Walter Sermeus
Journal:  BMC Health Serv Res       Date:  2010-08-23       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.